A. Balcomb

发表

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.

M. Alavi, G. Dore, P. Haber, 2015, The International journal on drug policy.

A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC trial)

A. Rodgers, G. Dore, A. Balcomb, 2021, Journal of viral hepatitis.

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia.

M. Alavi, G. Dore, P. Haber, 2017, Journal of addiction medicine.

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

M. Alavi, G. Dore, P. Haber, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Delivery of treatment for hepatitis C virus infection in the primary care setting

M. Alavi, G. Dore, A. Balcomb, 2014, European journal of gastroenterology & hepatology.

Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.

P. Read, G. Dore, A. Balcomb, 2021, The International journal on drug policy.

Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort

Jessica R. Ackerman, P. Read, G. Dore, 2022, Journal of viral hepatitis.

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.

M. Alavi, G. Dore, M. Weltman, 2016, Addiction.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study

M. Alavi, G. Dore, P. Haber, 2015, Journal of viral hepatitis.

High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study

P. Read, G. Dore, A. Balcomb, 2021, Hepatology communications.

Prescribing of direct‐acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program

G. Dore, A. Balcomb, J. Grebely, 2021, The Medical journal of Australia.

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

M. Alavi, G. Dore, P. Haber, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The immunisation cold chain. Why is it so hard to get right?

Ken Hazelton, Annie Balcomb, Kerrie Bowd, 2002, Australian family physician.